National Monkeypox Surveillance, Central African Republic, 2001-2021.

Central Africa Central African Republic emerging infectious diseases monkeypox monkeypox virus national surveillance outbreak investigation viruses zoonoses

Journal

Emerging infectious diseases
ISSN: 1080-6059
Titre abrégé: Emerg Infect Dis
Pays: United States
ID NLM: 9508155

Informations de publication

Date de publication:
12 2022
Historique:
pubmed: 4 11 2022
medline: 24 11 2022
entrez: 3 11 2022
Statut: ppublish

Résumé

We analyzed monkeypox disease surveillance in Central African Republic (CAR) during 2001-2021. Surveillance data show 95 suspected outbreaks, 40 of which were confirmed as monkeypox, comprising 99 confirmed and 61 suspected monkeypox cases. After 2018, CAR's annual rate of confirmed outbreaks increased, and 65% of outbreaks occurred in 2 forested regions bordering the Democratic Republic of the Congo. The median patient age for confirmed cases was 15.5 years. The overall case-fatality ratio was 7.5% (12/160) for confirmed and suspected cases, 9.6% (8/83) for children <16 years of age. Decreasing cross-protective immunity from smallpox vaccination and recent ecologic alterations likely contribute to increased monkeypox outbreaks in Central Africa. High fatality rates associated with monkeypox virus clade I also are a local and international concern. Ongoing investigations of zoonotic sources and environmental changes that increase human exposure could inform practices to prevent monkeypox expansion into local communities and beyond endemic areas.

Identifiants

pubmed: 36328951
doi: 10.3201/eid2812.220897
pmc: PMC9707566
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2435-2445

Références

Emerg Infect Dis. 2021 Apr;27(4):
pubmed: 33756100
J Infect Dis. 2004 Nov 15;190(10):1833-40
pubmed: 15499541
Emerg Infect Dis. 2001 May-Jun;7(3):434-8
pubmed: 11384521
Int J Infect Dis. 2022 Sep;122:647-655
pubmed: 35809857
J Virol Methods. 2010 Oct;169(1):223-7
pubmed: 20643162
Emerg Infect Dis. 2016 Jun;22(6):1014-21
pubmed: 27191380
Bull Soc Pathol Exot. 2016 Dec;109(5):358-363
pubmed: 27783372
Front Public Health. 2018 Sep 04;6:241
pubmed: 30234087
MMWR Morb Mortal Wkly Rep. 2018 Mar 16;67(10):306-310
pubmed: 29543790
Lancet Infect Dis. 2022 Aug;22(8):1153-1162
pubmed: 35623380
Sci Rep. 2021 Jun 22;11(1):13085
pubmed: 34158533
Ther Adv Infect Dis. 2022 Aug 26;9:20499361221124027
pubmed: 36051570
Expert Rev Anti Infect Ther. 2020 May;18(5):389-392
pubmed: 32096659
PLoS One. 2017 Feb 13;12(2):e0168664
pubmed: 28192435
Lancet Infect Dis. 2019 Aug;19(8):872-879
pubmed: 31285143
Clin Infect Dis. 2020 Nov 5;71(8):e210-e214
pubmed: 32052029
Am J Trop Med Hyg. 2005 Aug;73(2):428-34
pubmed: 16103616
Emerg Infect Dis. 2007 Jun;13(6):934-7
pubmed: 17553242
Proc Natl Acad Sci U S A. 2010 Sep 14;107(37):16262-7
pubmed: 20805472
Trends Microbiol. 2012 Feb;20(2):80-7
pubmed: 22239910
N Engl J Med. 2022 Aug 25;387(8):679-691
pubmed: 35866746
Viruses. 2020 Nov 05;12(11):
pubmed: 33167496
Int J Infect Dis. 2022 Sep;122:107-111
pubmed: 35640830
J Infect Dis. 2021 Jun 4;223(11):1870-1878
pubmed: 33728469
Emerg Infect Dis. 2019 May;25(5):1023-1025
pubmed: 30753125
Pan Afr Med J. 2015 Sep 10;22:23
pubmed: 26664524
PLoS One. 2013 Sep 05;8(9):e74816
pubmed: 24040344
Bull Soc Pathol Exot Filiales. 1985;78(3):311-20
pubmed: 2992830
Vaccine. 2011 Dec 30;29 Suppl 4:D54-9
pubmed: 22185831
PLoS Negl Trop Dis. 2019 Oct 16;13(10):e0007791
pubmed: 31618206
PLoS Negl Trop Dis. 2022 Feb 11;16(2):e0010141
pubmed: 35148313
Trop Geogr Med. 1988 Apr;40(2):73-83
pubmed: 2841783
Trop Geogr Med. 1987 Apr;39(2):115-22
pubmed: 2820094
Open Forum Infect Dis. 2017 Nov 03;4(4):ofx168
pubmed: 29732376
Bull World Health Organ. 1972;46(5):593-7
pubmed: 4340218
Ecohealth. 2020 Mar;17(1):64-73
pubmed: 31875271
Emerg Infect Dis. 2008 Apr;14(4):592-9
pubmed: 18394277
N Engl J Med. 2021 Apr 1;384(13):1240-1247
pubmed: 33789012
Infect Genet Evol. 2019 Apr;69:8-11
pubmed: 30634001
Emerg Infect Dis. 2019 Aug;25(8):1602-1604
pubmed: 31216261
J Infect Dis. 2022 Apr 19;225(8):1367-1376
pubmed: 32880628
Int J Trop Dis Health. 2017;25(2):
pubmed: 30123790
Am J Trop Med Hyg. 2007 Dec;77(6):1150-6
pubmed: 18165539
J Public Health Afr. 2022 May 25;13(1):2184
pubmed: 35720796
Med Mal Infect. 2018 Jun;48(4):263-268
pubmed: 29573840
Viruses. 2017 Sep 29;9(10):
pubmed: 28961172
PLoS One. 2019 Apr 17;14(4):e0214229
pubmed: 30995249
Lancet. 2011 Oct 8;378(9799):1354
pubmed: 21982097
Bull World Health Organ. 1988;66(4):465-70
pubmed: 2844429

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH